Position in HLN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,799
-$21,325 QoQ
Shares Held
300
-87.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#168
of 203 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HM PAYSON & CO holds $427,878 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (0.7% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,799 | 300 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $24,124 | 2,410 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $18,299 | 1,810 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $16,235 | 1,810 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $18,769 | 1,810 | Shares | Sole | 2025-10-17 | |
| 2025-03-31 | $18,624 | 1,810 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $17,267 | 1,810 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $19,149 | 1,810 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $14,950 | 1,810 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $15,366 | 1,810 | Shares | Sole | 2024-06-20 | |
| 2023-12-31 | $14,896 | 1,810 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $18,825 | 2,260 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $15,250 | 1,820 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $21,326 | 2,620 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $22,696 | 2,837 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $21,083 | 3,462 | Shares | Sole | 2022-10-25 | |
| No filing history on record for this holder in this stock. | ||||||